Insider Transactions in Q2 2022 at Biodesix Inc (BDSX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 10
2022
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
SELL
Open market or private sale
|
Direct |
3,338
-5.4%
|
$3,338
$1.83 P/Share
|
|
May 10
2022
|
Gary Anthony Pestano Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,467
-1.68%
|
$1,467
$1.83 P/Share
|
|
May 10
2022
|
Scott Hutton President & CEO |
SELL
Open market or private sale
|
Direct |
13,278
-23.24%
|
$13,278
$1.83 P/Share
|
|
May 10
2022
|
Robert William Georgantas Iii Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,004
-9.88%
|
$2,004
$1.83 P/Share
|
|
May 10
2022
|
Ryan H Siurek Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,947
-20.82%
|
$1,947
$1.83 P/Share
|
|
May 10
2022
|
Kieran O'Kane Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,583
-17.17%
|
$1,583
$1.83 P/Share
|
|
May 09
2022
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,575
+15.77%
|
-
|
|
May 09
2022
|
Gary Anthony Pestano Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,054
+5.48%
|
-
|
|
May 09
2022
|
Scott Hutton President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,778
+43.93%
|
-
|
|
May 09
2022
|
Robert William Georgantas Iii Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,647
+21.77%
|
-
|
|
May 09
2022
|
Ryan H Siurek Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,484
+36.97%
|
-
|
|
May 09
2022
|
Kieran O'Kane Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,461
+37.19%
|
-
|
|
Apr 07
2022
|
Jack W Schuler |
BUY
Open market or private purchase
|
Indirect |
2,793,296
+19.88%
|
$2,793,296
$1.79 P/Share
|
|
Apr 07
2022
|
Matthew Strobeck |
BUY
Open market or private purchase
|
Indirect |
558,659
+42.05%
|
$558,659
$1.79 P/Share
|
|
Apr 07
2022
|
Matthew Strobeck |
BUY
Open market or private purchase
|
Direct |
558,659
+26.55%
|
$558,659
$1.79 P/Share
|
|
Apr 07
2022
|
John Patience |
BUY
Open market or private purchase
|
Direct |
279,329
+45.25%
|
$279,329
$1.79 P/Share
|